986P Response to capmatinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) and MET exon 14 skipping (METex14) mutation: Whole transcriptome analysis from phase II GEOMETRY Mono-1 study

Autor: Wolf, J., Groen, H.J.M., Tan, D.S.W., Garon, E.B., Demanse, D., Robeva, A., Yovine, A., Fairchild, L., Boran, A.D., Heist, R.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1003-S1003
Databáze: ScienceDirect